17 March 2023

GSK Stockmann recognized by Chambers Europe 2023 and Chambers Global 2023

Chambers and Partners have published their 2023 rankings based on its annual research and recognize GSK Stockmann with practice and individual mentions in their Chambers Europe and Chambers Global editions.

The following practices are ranked by Chambers Europe 2023:

  • Banking & Finance Regulatory (Germany)
  • Banking & Finance (Luxembourg)
  • Corporate/M&A: Mid-Market (Germany)
  • Investment Funds (Germany)
  • Projects: Construction (Germany)
  • Public Law: Planning and Environment (Germany)
  • Real Estate (Germany)

The following lawyers are ranked by Chambers Europe 2023:

  • Dr. Dirk Brückner, Real Estate (Germany)
  • Dr. Michael Eggersberger, Real Estate (Germany)
  • Dr. Friedrich Hausmann, Public Law: Public Procurement (Germany)
  • Andreas Heinzmann, Capital Markets (Luxembourg)
  • Stefan Koser, Real Estate Finance (Germany)
  • Eric Mayer, Compliance (Germany)
  • Prof. Dr. Oliver Moufang, Projects: Construction (Germany)
  • Mathilde Ostertag, Tax (Luxembourg)

The following practices are ranked by Chambers Global 2023:

  • Banking & Finance Regulatory (Germany)
  • Capital Markets (Germany)
  • Banking & Finance (Luxembourg)

The following lawyers are ranked Chambers Global 2023:

  • Andreas Heinzmann, Capital Markets (Germany, Luxembourg)
  • Dr. Philipp Mößner Capital Markets (Germany, Luxembourg), Corporate/M&A (Luxembourg)
  • Dr. Marcus Peter, Investment Funds (Luxembourg)

The full results are available at Chambers Europe 2023 and Chambers Global 2023.

Chambers Europe and Chambers Global rankings are published by Chambers and Partners, an independent research company operating across 200 jurisdictions delivering detailed rankings and insight into the world’s leading lawyers. The results are based on a combination of research and client feedback with ratings on legal skills, professional conduct, client service and commercial awareness.

Print


Press contact
presse@gsk.de
+49 30 203907-7763

Back

GSK Updates
  • 23 February 2023

    GSK Update: On-shore power in ports: Once optional, soon a requirement

    Read more
  • 22 February 2023

    GSK Update: Expansion of Transparency Register notification obligation – extensive (subsequent) reporting requirements for foreign legal entities

    Read more
  • 06 February 2023

    GSK Update: Corporate News: Mobility Directive soon to be transposed in Germany and Luxembourg

    Read more

For reasons of better readability, we use the gender-neutral generic masculine. However, the information expressly refers to all genders.

CO2 Neutral